Potential of COVID-19 convalescent plasma for future monoclonal antibodies against severe SARS-CoV-2 inflammation

Researchers report that convalescent plasma treatment is most effective in treating hospitalized COVID-19 patients.

Related Keywords

United States ,Maxim Krivonos ,University Of Pennsylvania ,Drug Administration ,World Health Organization ,United States Food ,Clinical Severity Score ,Antibodies ,Convalescent Plasma ,Coronavirus Disease Covid 19 ,Inflammation ,Cars ,Ars Cov 2 ,Ntibody ,Ntigen ,Anti Inflammatory ,Flood ,Coronavirus ,Efficacy ,Influenza ,Lassa Virus ,Ortality ,Utation ,Pandemic ,Phagocytosis ,Espiratory ,Serology ,Evere Acute Respiratory ,Evere Acute Respiratory Syndrome ,Yndrome ,Herapeutics ,Vaccine ,Virus ,